These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 6695816)

  • 1. Electrophysiologic properties of flecainide acetate.
    Estes NA; Garan H; Ruskin JN
    Am J Cardiol; 1984 Feb; 53(5):26B-29B. PubMed ID: 6695816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrograde gap in fast pathway conduction accentuated by the class I antiarrhythmic agent, flecainide.
    Bexton RS; Hellestrand KJ; Nathan AW; Banim SO; Camm AJ
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1273-7. PubMed ID: 6196737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.
    Hellestrand KJ; Nathan AW; Bexton RS; Camm AJ
    Am J Cardiol; 1984 Feb; 53(5):30B-38B. PubMed ID: 6695817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunction.
    Vik-Mo H; Ohm OJ; Lund-Johansen P
    Am J Cardiol; 1982 Nov; 50(5):1090-4. PubMed ID: 7137036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.
    Hellestrand KJ; Bexton RS; Nathan AW; Spurrell RA; Camm AJ
    Br Heart J; 1982 Aug; 48(2):140-8. PubMed ID: 7093083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine electrophysiology of encainide, a new antiarrhythmic drug.
    Sami M; Mason JW; Oh G; Harrison DC
    Am J Cardiol; 1979 Jun; 43(6):1149-54. PubMed ID: 443174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agent.
    Greene HL; Werner JA; Gross BW; Sears GK; Trobaugh GB; Cobb LA
    Am Heart J; 1983 Sep; 106(3):492-501. PubMed ID: 6881021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate.
    Bexton RS; Hellestrand KJ; Nathan AW; Spurrell RA; Camm AJ
    Eur Heart J; 1983 Feb; 4(2):92-102. PubMed ID: 6852073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
    Ikeda N; Singh BN; Davis LD; Hauswirth O
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):303-10. PubMed ID: 3968315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic evaluation of intravenous verapamil in man.
    Rizzon P; Di Biase M; Calabrese P; Brindicci G; Chiddo A
    Eur J Cardiol; 1977; 6(3):179-94. PubMed ID: 338305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiarrhythmic drugs on AV nodal and intraventricular conduction as assessed in the isolated, blood-perfused AV node preparation of the dog.
    Satoh K; Narimatsu A; Taira N
    J Cardiovasc Pharmacol; 1981; 3(4):753-68. PubMed ID: 6167805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of flecainide on atrioventricular conduction properties in the adult and immature rabbit heart.
    Han HS; Hewett KW; McKay CA; Gillette PC; Case CL
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):767-76. PubMed ID: 9512872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of ethmozine in perfused rabbit hearts.
    Dresel PE; Ogbaghebriel A; Abraham R
    Can J Physiol Pharmacol; 1985 Nov; 63(11):1418-22. PubMed ID: 3907808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
    Sassine A; Masse C; Fajuri A; Hirsch JL; Labrid C; Puech P
    Am J Cardiol; 1984 Jun; 53(11):1707-11. PubMed ID: 6610347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological actions of lorcainide in patients with cardiac disease.
    Kasper W; Meinertz T; Kersting F; Löllgen H; Lang K; Just H
    J Cardiovasc Pharmacol; 1979; 1(3):343-52. PubMed ID: 94401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.